BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31696210)

  • 1. Wogonoside inhibits tumor growth and metastasis in endometrial cancer via ER stress-Hippo signaling axis.
    Chen S; Wu Z; Ke Y; Shu P; Chen C; Lin R; Shi Q
    Acta Biochim Biophys Sin (Shanghai); 2019 Nov; 51(11):1096-1105. PubMed ID: 31696210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wogonoside inhibits angiogenesis in breast cancer via suppressing Wnt/β-catenin pathway.
    Huang Y; Zhao K; Hu Y; Zhou Y; Luo X; Li X; Wei L; Li Z; You Q; Guo Q; Lu N
    Mol Carcinog; 2016 Nov; 55(11):1598-1612. PubMed ID: 26387984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wogonoside Inhibits Prostate Cancer Cell Growth and Metastasis via Regulating Wnt/β-Catenin Pathway and Epithelial-Mesenchymal Transition.
    Wei C; Jing J; Zhang Y; Fang L
    Pharmacology; 2019; 104(5-6):312-319. PubMed ID: 31480051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wogonoside induces growth inhibition and cell cycle arrest via promoting the expression and binding activity of GATA-1 in chronic myelogenous leukemia cells.
    Li H; Hui H; Xu J; Yang H; Zhang X; Liu X; Zhou Y; Li Z; Guo Q; Lu N
    Arch Toxicol; 2016 Jun; 90(6):1507-22. PubMed ID: 26104856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling.
    Huang Y; Fang J; Lu W; Wang Z; Wang Q; Hou Y; Jiang X; Reizes O; Lathia J; Nussinov R; Eng C; Cheng F
    Cell Chem Biol; 2019 Aug; 26(8):1143-1158.e6. PubMed ID: 31178408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wogonoside induces autophagy in MDA-MB-231 cells by regulating MAPK-mTOR pathway.
    Sun Y; Zou M; Hu C; Qin Y; Song X; Lu N; Guo Q
    Food Chem Toxicol; 2013 Jan; 51():53-60. PubMed ID: 23000445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wogonoside induces autophagy-related apoptosis in human glioblastoma cells.
    Zhang L; Wang H; Cong Z; Xu J; Zhu J; Ji X; Ding K
    Oncol Rep; 2014 Sep; 32(3):1179-87. PubMed ID: 24970553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wogonoside exerts growth-suppressive effects against T acute lymphoblastic leukemia through the STAT3 pathway.
    Xiao R; Gan M; Jiang T
    Hum Exp Toxicol; 2017 Nov; 36(11):1169-1176. PubMed ID: 27941168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wogonoside inhibits lipopolysaccharide-induced angiogenesis in vitro and in vivo via toll-like receptor 4 signal transduction.
    Chen Y; Lu N; Ling Y; Gao Y; Wang L; Sun Y; Qi Q; Feng F; Liu W; Liu W; You Q; Guo Q
    Toxicology; 2009 May; 259(1-2):10-7. PubMed ID: 19428938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wogonoside promotes apoptosis in gastric cancer AGS and SGC-7901 cells through induction of mitochondrial dysfunction and endoplasmic reticulum stress.
    Hu XM; Xiang JJ; Xiao BL; Huang YF; Xie JP
    FEBS Open Bio; 2019 Aug; 9(8):1469-1476. PubMed ID: 31250981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wogonoside induces apoptosis in human non-small cell lung cancer A549 cells by promoting mitochondria dysfunction.
    Luo M; Mo J; Yu Q; Zhou S; Ning R; Zhang Y; Su C; Wang H; Cui J
    Biomed Pharmacother; 2018 Oct; 106():593-598. PubMed ID: 29990847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway.
    Sun Y; Zhao Y; Wang X; Zhao L; Li W; Ding Y; Kong L; Guo Q; Lu N
    Oncotarget; 2016 Jun; 7(23):34300-15. PubMed ID: 27102438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cells.
    Chen Y; Hui H; Yang H; Zhao K; Qin Y; Gu C; Wang X; Lu N; Guo Q
    Blood; 2013 May; 121(18):3682-91. PubMed ID: 23487022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wogonoside inhibits invasion and migration through suppressing TRAF2/4 expression in breast cancer.
    Yao Y; Zhao K; Yu Z; Ren H; Zhao L; Li Z; Guo Q; Lu N
    J Exp Clin Cancer Res; 2017 Aug; 36(1):103. PubMed ID: 28774312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifunctional effects of O-methylated flavones from Scutellaria baicalensis Georgi on melanocytes: Inhibition of melanin production and intracellular melanosome transport.
    Kudo M; Kobayashi-Nakamura K; Tsuji-Naito K
    PLoS One; 2017; 12(2):e0171513. PubMed ID: 28182699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective mechanisms of wogonoside against Lipopolysaccharide/D-galactosamine-induced acute liver injury in mice.
    Gao YZ; Zhao LF; Ma J; Xue WH; Zhao H
    Eur J Pharmacol; 2016 Jun; 780():8-15. PubMed ID: 26921756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deglycosylation of wogonoside enhances its anticancer potential.
    Wang CZ; Wan JY; Zhang CF; Lu F; Chen L; Yuan CS
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S594-S599. PubMed ID: 30249874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wogonoside impedes the progression of acute myeloid leukemia through inhibiting bone marrow angiogenesis.
    Lin B; Zhao K; Yang D; Bai D; Liao Y; Zhou Y; Yu Z; Yu X; Guo Q; Lu N
    J Cell Physiol; 2019 Feb; 234(2):1913-1924. PubMed ID: 30105796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLSCR1/IP3R1/Ca
    Li H; Xu J; Zhou Y; Liu X; Shen LE; Zhu YU; Li Z; Wang X; Guo Q; Hui H
    Cell Death Dis; 2017 May; 8(5):e2768. PubMed ID: 28492556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wogonoside displays anti-inflammatory effects through modulating inflammatory mediator expression using RAW264.7 cells.
    Yang YZ; Tang YZ; Liu YH
    J Ethnopharmacol; 2013 Jun; 148(1):271-6. PubMed ID: 23612420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.